title: Immediate or delayed docetaxel: does progression-free survival really reflect two strategies?
authors.forename: Hüseyin
authors.initials: H
authors.lastname: Abali
authors.forename: Umut
authors.initials: U
authors.lastname: Disel
authors.forename: Fatih
authors.initials: F
authors.lastname: Köse
authors.forename: Ahmet
authors.initials: A
authors.lastname: Sezer
authors.forename: Hüseyin
authors.initials: H
authors.lastname: Mertsoylu
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000401:mortality*; D003692:Delayed-Action Preparations; D018572:Disease-Free Survival; D000077143:Docetaxel; D004358:Drug Therapy / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality*; D010829:Physiological Phenomena; D016019:Survival Analysis; D043823:Taxoids / Q000737:chemistry* / Q000627:therapeutic use
chemical_list: D003692:Delayed-Action Preparations; D043823:Taxoids; D000077143:Docetaxel